Source: Annual Congress 2012 - New insights into airway epithelial cell physiology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Ruffin, S. Marie, C. Charlier, H. Corvol, A. Clement, O. Tabary (Paris, France). ANO1 expression and activity in cystic fibrosis. Eur Respir J 2012; 40: Suppl. 56, 4738

Member's Comments

No comment yet.

Related content which might interest you: Atypical cystic fibrosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=38 Year: 2006 CFTR: cystic fibrosis and beyond Source: Eur Respir J 2014; 44: 1042-1054 Year: 2014 Targeting CFTR as a therapy for cystic fibrosis Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung Year: 2010 Expression of the nuclear factor-?B inhibitor A20 is altered in the cystic fibrosis epithelium Source: Eur Respir J 2013; 41: 1315-1323 Year: 2013 Dysregulation of the expression and activity of antimicrobial peptides in COPD and cystic fibrosis Source: International Congress 2018 – Antimicrobial host defence and innate immunity in the lung Year: 2018 Increased epithelial production of LPLUNC1 in cystic fibrosis lung disease Source: Annual Congress 2011 - Epithelial cell biology Year: 2011 A three miRNA signature regulates the CF transmembrane conductance regulator (CFTR) in cystic fibrosis airway epithelium Source: Annual Congress 2011 - Epithelial cells: role in health and disease Year: 2011 Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis Source: Eur Respir Rev 2013; 22: 58-65 Year: 2013 TLR-4 expression is reduced in cystic fibrosis bronchial epithelial cells Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008 Expression of HCLCA1 in cystic fibrosis lungs is associated with mucus overproduction Source: Eur Respir J 2004; 23: 846-850 Year: 2004 The CFTR and EGFR relationship in airway vascular growth, and its importance in cystic fibrosis Source: Eur Respir J 2013; 42: 1438-1440 Year: 2013 CFTR regulation by microRNA-145, -223 and -494 is altered in deltaF508 cystic fibrosis airway epithelium Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 MiRNA expression profile is altered upon cystic fibrosis pulmonary exacerbation Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 Identification of a new cystic fibrosis transmembrane regulator mutation in a severely affected patient Source: Eur Respir J 2002; 19: 374-376 Year: 2002 Comparative expression of SPLUNC1 and LPLUNC1 in normal and cystic fibrosis lung Source: Annual Congress 2007 - Epithelial networks in the airways Year: 2007 Potentiating and correcting mutant CFTR in patients with cystic fibrosis Source: Eur Respir Monogr 2014; 64: 129-149 Year: 2014 The effect of CFTR modulators on CT outcomes in cystic fibrosis Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis Year: 2019 The TLR4 regulator miR-21 is downregulated in the paediatric cystic fibrosis airway Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 Neomacrolides in cystic fibrosis Source: Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease Year: 2012